Galapagos Stock

Galapagos Net Margin

The Net Profit Margin of Galapagos (GLPG.AS) as of Aug 6, 2026 is 28.85 %. In the previous year, Net Profit Margin was 26.88 % — a change of 7.35% (higher).

Net Margin

28.85 %

YoY

7.35%

Last updated:

Net Profit Margin of Galapagos is 2026 28.85 % . Net Profit Margin of Galapagos was 2025 26.88 % . It decreases by 7.35% higher compared to the previous year.

Galapagos's net margin stands at 28.9%, up from -25.9% several years earlier.

Access this data via the Eulerpool API

Galapagos Stock analysis

What does Galapagos do? Galapagos NV is a Belgian biopharmaceutical company focused on the development of novel drugs, particularly for autoimmune diseases and fibrosis. The company was founded in 1999 by Onno van de Stolpe and is headquartered in Mechelen, Belgium. Galapagos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Galapagos stock

Net Profit Margin of Galapagos is 28.85 % in 2026.

Net Profit Margin of Galapagos changed from 26.88 % to 28.85 %, representing a 7.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Galapagos since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Galapagos with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Galapagos

All Key Metrics — Galapagos